Results Salarius Pharmaceuticals Inc.
-
8/27
-
8/26
-
Amendment to Current Report (Form 8-K/A)
8/26
-
Supplemental Prospectus (Form 424B5)
8/22
-
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (Form 8-K)
8/22
-
Management Change/Compensation (Form 8-K)
8/18
-
Registration Statement - Specified Transactions (Form S-3)
8/15
-
Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)
8/12
-
Amendment to Initial Registration Statement (Form S-1/A)
8/8
-
Free Writing Prospectus (Form FWP)
8/5